CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
131 hedge funds and large institutions have $458M invested in Cymabay Therapeutics in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 37 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
26% less capital invested
Capital invested by funds: $623M → $458M (-$165M)
45% less call options, than puts
Call options by funds: $250K | Put options by funds: $454K
Holders
131
Holding in Top 10
4
Calls
$250K
Puts
$454K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.69M | |
| 3 | +$4.78M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.69M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.92M |
Top Sellers
| 1 | -$9M | |
| 2 | -$8.12M | |
| 3 | -$4.55M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$2.36M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.2M |